Nexalis Therapeutics Limited (ASX:NX1)

Nexalis Therapeutics Revenue

In the year 2025, Nexalis Therapeutics had annual revenue of 767.69K AUD with 91.06% growth. Nexalis Therapeutics had revenue of 557.12K in the half year ending June 30, 2025, with 27.13% growth.

• Revenue: 767.69K
• Revenue Growth: +91.06%
• P/S Ratio: 8.24
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 6.33M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	767.69K	365.88K	91.06%
Dec 31, 2024	401.81K	-802.24K	-66.63%
Dec 31, 2023	1.20M	1.18M	4,755.02%
Dec 31, 2022	24.80K	-156.94K	-86.35%
Dec 31, 2021	181.74K	159.61K	721.35%